Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study

Basit Öğe Kaydı
dc.authorid0000-0002-0678-4024
dc.authorid0000-0003-1018-1119
dc.authorid0000-0001-5885-3047
dc.authorid0000-0003-0411-8818
dc.contributor.authorOzgun, M. A.
dc.contributor.authorDogan, I.
dc.contributor.authorEryilmaz, M. Karakurt
dc.contributor.authorErdogan, A. P.
dc.contributor.authorAyhan, M.
dc.contributor.authorHafizoglu, E.
dc.contributor.authorTolunay, P. K.
dc.date.accessioned2025-05-10T19:48:31Z
dc.date.issued2021
dc.departmentİstanbul Medeniyet Üniversitesi
dc.descriptionCongress of the European-Society-for-Medical-Oncology (ESMO) -- SEP 16-21, 2021 -- ELECTR NETWORK
dc.description.abstract[No abstract available]
dc.description.sponsorshipEuropean Soc Med Oncol,Japanese Soc Med Oncol
dc.identifier.doi10.1016/j.annonc.2021.08.1461
dc.identifier.endpageS892
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.scopusqualityQ1
dc.identifier.startpageS892
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2021.08.1461
dc.identifier.urihttps://hdl.handle.net/20.500.14730/11733
dc.identifier.volume32
dc.identifier.wosWOS:000700527702094
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofAnnals of Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.titleReal-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study
dc.typeConference Object

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
11733.pdf
Boyut:
93.12 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu